company background image
GDRX

GoodRx Holdings NasdaqGS:GDRX Stock Report

Last Price

US$5.41

Market Cap

US$2.2b

7D

-0.4%

1Y

-24.9%

Updated

07 Jun, 2023

Data

Company Financials +

GDRX Stock Overview

GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.

GDRX fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Rewards

Trading at 51% below our estimate of its fair value

Earnings are forecast to grow 64.49% per year

Risk Analysis

No risks detected for GDRX from our risk checks.

My Notes

Capture your thoughts, links and company narrative

GoodRx Holdings, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GoodRx Holdings
Historical stock prices
Current Share PriceUS$5.41
52 Week HighUS$10.37
52 Week LowUS$3.82
Beta0.89
1 Month Change17.35%
3 Month Change-1.46%
1 Year Change-24.86%
3 Year Changen/a
5 Year Changen/a
Change since IPO-89.29%

Recent News & Updates

GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

May 27
GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

Recent updates

GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

May 27
GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

May 05
Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

May 05
Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

Mar 23
Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Feb 07
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

GoodRx Holdings (NASDAQ:GDRX) Could Be Struggling To Allocate Capital

Nov 02
GoodRx Holdings (NASDAQ:GDRX) Could Be Struggling To Allocate Capital

GoodRx laying off 140 employees, 16% of workforce

Aug 31

GoodRx: Trending Positive, But Not A Buy Yet

Aug 25

GoodRx: Unexpected Short Squeeze As Grocer Issue Resolved

Aug 09

GoodRx: Unexpected Wrench Pushes Me To The Sidelines

Jul 25

Here's What's Concerning About GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital

Jul 20
Here's What's Concerning About GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital

GoodRx: Guidance Gets Worse, Stay Clear

May 19

GoodRx: Time To Buy The Dip

Apr 23

Returns On Capital Signal Tricky Times Ahead For GoodRx Holdings (NASDAQ:GDRX)

Apr 19
Returns On Capital Signal Tricky Times Ahead For GoodRx Holdings (NASDAQ:GDRX)

GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Intrinsic Value Is Potentially 80% Above Its Share Price

Mar 21
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Intrinsic Value Is Potentially 80% Above Its Share Price

GoodRx: Q4 Earnings, Guidance Is Not The Only Problem

Mar 01

GoodRx: A Great Business Now At A Discount

Jan 28

GoodRx Is Growing Revenue And In Healthcare Services Sweet Spot

Jan 05

GoodRx: Formidable Tech Company Taking On Underpenetrated Health Market

Dec 19

Calculating The Intrinsic Value Of GoodRx Holdings, Inc. (NASDAQ:GDRX)

Nov 28
Calculating The Intrinsic Value Of GoodRx Holdings, Inc. (NASDAQ:GDRX)

GoodRx: Hold On For More Upside

Sep 28

GoodRx Needs A Transformation Script

Sep 16

Saga Partners H1 2021 Investor Letter

Aug 24

GoodRx Holdings, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 15
GoodRx Holdings, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Are Investors Undervaluing GoodRx Holdings, Inc. (NASDAQ:GDRX) By 50%?

Aug 14
Are Investors Undervaluing GoodRx Holdings, Inc. (NASDAQ:GDRX) By 50%?

GoodRx: David Becomes Goliath

Aug 13

GoodRx: The Growth Runway Is Long

Jul 29

Sell GoodRx, An Unnecessary Middleman

Jun 07

GoodRx: A Battered Stock With Tremendous Upside

May 26

GoodRx rises on bullish call from RBC Capital Markets

Apr 27

Shareholder Returns

GDRXUS Healthcare ServicesUS Market
7D-0.4%12.0%2.5%
1Y-24.9%-6.2%1.3%

Return vs Industry: GDRX underperformed the US Healthcare Services industry which returned -6.2% over the past year.

Return vs Market: GDRX underperformed the US Market which returned 1.3% over the past year.

Price Volatility

Is GDRX's price volatile compared to industry and market?
GDRX volatility
GDRX Average Weekly Movement6.9%
Healthcare Services Industry Average Movement7.8%
Market Average Movement6.6%
10% most volatile stocks in US Market15.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: GDRX is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: GDRX's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2015953Scott Wagnerhttps://www.goodrx.com

GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services.

GoodRx Holdings, Inc. Fundamentals Summary

How do GoodRx Holdings's earnings and revenue compare to its market cap?
GDRX fundamental statistics
Market CapUS$2.19b
Earnings (TTM)-US$48.41m
Revenue (TTM)US$747.21m

2.9x

P/S Ratio

-44.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
GDRX income statement (TTM)
RevenueUS$747.21m
Cost of RevenueUS$69.49m
Gross ProfitUS$677.72m
Other ExpensesUS$726.13m
Earnings-US$48.41m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.12
Gross Margin90.70%
Net Profit Margin-6.48%
Debt/Equity Ratio79.5%

How did GDRX perform over the long term?

See historical performance and comparison